Belite Bio Inc Statistics
Share Statistics
Belite Bio Inc has 31.83M
shares outstanding. The number of shares has increased by 6.82%
in one year.
| Shares Outstanding | 31.83M |
| Shares Change (YoY) | 6.82% |
| Shares Change (QoQ) | 3.07% |
| Owned by Institutions (%) | 0.92% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 191 |
| FTD / Avg. Volume | 0.47% |
Short Selling Information
The latest short interest is 60.69K, so 0.19% of the outstanding
shares have been sold short.
| Short Interest | 60.69K |
| Short % of Shares Out | 0.19% |
| Short % of Float | 0.41% |
| Short Ratio (days to cover) | 1.27 |
Valuation Ratios
The PE ratio is -53.31 and the forward
PE ratio is -40.46.
Belite Bio Inc's PEG ratio is
63.44.
| PE Ratio | -53.31 |
| Forward PE | -40.46 |
| PS Ratio | 0 |
| Forward PS | 7.7 |
| PB Ratio | 13.21 |
| P/FCF Ratio | -65.58 |
| PEG Ratio | 63.44 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Belite Bio Inc.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 24.31,
with a Debt / Equity ratio of 0.
| Current Ratio | 24.31 |
| Quick Ratio | 24.31 |
| Debt / Equity | 0 |
| Debt / EBITDA | -0.02 |
| Debt / FCF | -0.02 |
| Interest Coverage | -1999.8 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,445,760 |
| Employee Count | 25 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 6K |
| Effective Tax Rate | -0.02% |
Stock Price Statistics
The stock price has increased by 43.36% in the
last 52 weeks. The beta is -1.48, so Belite Bio Inc's
price volatility has been lower than the market average.
| Beta | -1.48 |
| 52-Week Price Change | 43.36% |
| 50-Day Moving Average | 62.02 |
| 200-Day Moving Average | 59.1 |
| Relative Strength Index (RSI) | 50.92 |
| Average Volume (20 Days) | 40,255 |
Income Statement
| Revenue | n/a |
| Gross Profit | -449K |
| Operating Income | -40M |
| Net Income | -36.14M |
| EBITDA | -35.67M |
| EBIT | -36.12M |
| Earnings Per Share (EPS) | -1.18 |
Full Income StatementBalance Sheet
The company has 31.68M in cash and 537K in
debt, giving a net cash position of 31.14M.
| Cash & Cash Equivalents | 31.68M |
| Total Debt | 537K |
| Net Cash | 31.14M |
| Retained Earnings | -107.65M |
| Total Assets | 152.13M |
| Working Capital | 141.02M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -29.23M
and capital expenditures -151K, giving a free cash flow of -29.39M.
| Operating Cash Flow | -29.23M |
| Capital Expenditures | -151K |
| Free Cash Flow | -29.39M |
| FCF Per Share | -0.96 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
